The use of the tetrahydropyranyl (Thp) group for the protection of serine and threonine side-chain hydroxyl groups in solid-phase peptide synthesis has not been widely investigated. Ser/Thr side-chain hydroxyl protection with this acid-labile and non-aromatic moiety is presented here. Although Thp reacts with free carboxylic acids, it can be concluded that to introduceT hp ethers at the hydroxyl groups of N-protected Ser and Thr,p rotection of the C-terminal carboxyl group is unnecessary due to the lability of Thp esters. Thp-protected Ser/Thrcontaining tripeptides are synthesized andt he removal of Thp studied in low concentrationso ft rifluoroacetic acid in the presenceo fc ation scavengers. Given its general stabilityt o most non-acidic reagents, improved solubility of its conjugates and ease with which it can be removed,T hp emerges as an effective protecting group for the hydroxyl groups of Ser and Thr in solid-phase peptide synthesis.
Since the first synthesis of at etrapeptide on as olids upport in 1963, [1] methodological advances in solid-phase peptide synthesis (SPPS) have allowed the preparation of av ast number of complexp eptides. [2] Accordingly,akeyf actor in peptide science is amino acid side-chain protection, ap rocedureu sed to preventu ndesired side reactions. In peptide and protein science, serine (Ser) and threonine (Thr) play important roles as their hydroxyl side chains are crucial as phosphorylation and O-glycosylation sites, [3, 4] as well as for the preparation of depsipeptides, [5, 6] among other molecules.F rom as ynthetic point of view,h ydroxyl-containing amino acids can be introduced into peptides without side-chain protection. [7] However,u nprotected hydroxyl functionalities in Ser and Thr can undergo side reactions such as dehydration or O-acylation, followed by O!N migration after amino group deprotection,p articularly in the presence of powerful activating agentss uch as carbodiimides. [7] This undesirable reaction is more predominant for the primary alcohol of Ser than fort he secondary alcohol of Thr.S ome studies have demonstrated peptide synthesis without the protection of the hydroxyl side chains of Ser and Thr; however,c are must be taken in choosing the activating agents. [8, 9] This point is especiallyr elevant in SPPS because this method involves the use of an excess of activating agents. [10] Thus, it can be concluded that the safestw ay to introduce hydroxylated amino acids is by protecting their side chains.
In peptide synthesis, hydroxyl functionalities arep rotected as ethers, which are more stable than the corresponding carbamates. Moreover, ethers are less pronet ot aking part in side reactions. [11] The most widely used hydroxyl protectingg roups for the common tert-butyloxycarbonyl (Boc) and 9-fluorenylmethyloxycarbonyl (Fmoc) strategies are benzyla nd tert-butyl (tBu), respectively.T rityl has been used less often for Ser and Thr in SPPS [12, 13] because trityl ethers are much more sensitive to acidic conditions than the corresponding tBu ethers. Additionally,t rityl-protected Ser and Thr can be selectively removed in the presence of a tBu ether in SPPS with al ow concentration of trifluoroacetic acid (TFA), [14] quirementf or ac oncentration of at least 50 %TFA for cleavage of tBu ethers. [13] Te trahydropyranyl (Thp) [15] is widely used as ah ydroxyl protecting group in organic chemistry [16] due to its low cost, ease of introduction, general stability to most non-acidic reagents, good solubility,a nd the easew ith whichi tc an be removed if the functional group it protects requires furtherm anipulation. [17] Accordingly,T hp has additional advantages over benzyl-based protecting groups as it lacks aromaticity and is characterized by atom economy and better solubility.I na ddition to producing more protectedh ydrophobic peptides, the use of bulky or aromaticp rotecting groups in SPPS affects inter-/intrachain interactions during peptide elongation and could therefore dramatically affect the purity of the final product. [18] The main drawback of using Thp in organic synthesis is the formation of an ew stereocenter,w hichl eads to diastereomeric mixtures. However,i fT hp is used as ap rotecting group or linker in SPPS, its use is temporary,a nd therefore the formation of anew stereocenter is not al imitation.
As Thp has received little attention as ap rotecting group in SPPS, we decidedt os tudy itsp otential for protecting Ser and Thr.There are only afew examples of the use of Thp to protect the side chains of Ser [19] [20] [21] [22] [23] [24] and Thr. [25, 26] Furthermore, the methods described in the literature for the protection of Ser and Thr hydroxyl groups involve prior protection of the carboxyl group. Here we report an efficient method for Thpp rotection of the hydroxyl side chains of Ser and Thr with free carboxyl groups andi ts application in SPPS.
In 2006, Krishnamoorthy et al. introduced Thp as aprotecting group for the Thr side chain in the synthesis of callipeltin B. [25] For the introductiono fT hp into the side chain of Thr,t he authors used Fmoc-Thr-OAllyl asaprecursor,w hich was reacted with dihydropyran (DHP) in the presence of pyridinium p-toluenesulfonate (PPTS) using dichloroethane as solvent. The reaction was allowed to react at 60 8Cf or 12 h. Removal of the allyl group afforded the desired Fmoc-Thr(Thp)-OH, which was used in the next step without purification. However,w es ynthesized Fmoc-Ser(Thp)/Thr(Thp)-OH in good yield using an acid-catalyzed reactionb etween Fmoc-Ser/Thr-OH and DHP, with p-toluenesulfonic acid (PTSA)a sc atalyst and dichloromethane as solvent. We found that protection of the carboxyl group was unnecessary. Although carboxylic acids reacts with DHP similarly to alcohols, the corresponding hemiacetal ester is unstable, and during the work-up the Thp was cleaved from the carboxyl group. [27, 28] Thus, Fmoc-Thr/Ser-OH can be sidechain protected withoutt he need for protection of the carboxyl group. This is highly relevant when dealing with the protection of unnatural w-hydroxy amino acids that are difficult to synthesize. Examples of such compounds include allo-Thr derivatives and other b-hydroxy amino acids that are natural cyclodepsipeptides. [29, 30] Furthermore,w ed emonstrated that PTSA is am ore convenient and more efficient catalyst than PPTS, ast he latter requires the reactionm ixture to be heated to nearly 60 8Cf or 10-12 h. PTSA was am ore efficient catalyst as the reaction rate increased( reaction time < 60 min at room temperature) compared to PPTS. The use of Thp as aprotecting group for the hydroxyl side chain in Fmoc-Ser/Thr-OH increased the solubility of the amino acid, which is consistent with our earlier reports. [18] In order to determinethe acid stability of Thpasaprotecting group, Fmoc-Ser(Thp)-OH and Fmoc-Thr(Thp)-OH weres tudied under ar ange of acidolytic conditions ( Table 1 ). The labilityo f the Thp group was greatlyi ncreased in the presence of triisopropylsilane (TIS) as as cavenger comparedw ith H 2 O ( Table 1 , entries 3a nd 4). Furthermore, we prepared the model Thp-protected tripeptides Fmoc-Ala-Xxx(Thp)-Leu-O-2CTC (where Xxx = Ser or Thr,2 CTC = 2-chlorotrityl chloride) using N,N'-diisopropylcarbodiimide( 3equiv.) and ethyl (hydroxyimino)cyanoacetate (Oxyma Pure, 3equiv.) in N,N-dimethylformamide (DMF) with a3min pre-activation time and 1.5 hc oupling time at 25 8C. Both Thp-protected Ser and Thr were stable under the coupling conditions tested and also to the Fmoc deprotection in piperidine/DMF (1:4). In additional, the lability of the synthesized tripeptides was also studied under the indicated cleavage conditions (Scheme 1a nd Table 2 ). During tripeptide elongation, the Thp group remained stable and was cleaved with al ow concentration of TFAt oa fford the deprotected tripeptide, as shown by the HPLC chromatograms( see the Supporting Information). Complete cleavage was obtained in the presence of TIS as as cavenger anda tl ow TFAc oncentration ( Table 2 , entries 2a nd 7).
In addition to the aforementioned use of Thp as aprotecting group, the Thp moiety was also studied as ac leavable linker for SPPS. Ellmanr esin has been found to be convenient for the synthesis of aw ide range of hydroxyl-containing organic compounds. [31] However,t here are only af ew reports on the use of this resin for the synthesis of peptide alcohols. [32] Taking these facts into consideration, we attempted to introduce Fmoc-Ser/ Thr-NH 2 onto Ellman resin using PTSA as catalysta nd CH 2 Cl 2 / THF (1:4) as solvent. However,w ew ere unable to anchori t onto the resin due to solubility issues. Therefore, Fmoc-SerOMe was attached to Ellman resin under similarr eaction conditions using PTSA as catalysta nd THF as solvent. Cleavage studies revealed that Fmoc-Ser-OMe anchored to Ellman resin at the hydroxyl side chain even in THF.
In summary,w es tudied the PTSA-catalyzed Thp protection of the hydroxyl side chains of Ser and Thr.O ur findings reveal that there is no need to protect the C-terminal carboxyl group, as the corresponding hemiacetale ster is unstable, and Thp is removedf rom the carboxyl group during aqueous work-up. We also conclude that the deprotection of Thp from side chains of Ser and Thr can be achieved using lower concentrations of TFA( 2%)i nt he presence of water and TIS as scavengers over short reactiont imes (approximately 15 min). Unexpectedly, Thpp rotection of the hydroxyl side chain of Thr was slightly more unstablet han that of Ser.S imilar trends have been found for model peptides using 2-CTC resin. The Thp group was stable during peptidee longation and the Fmoc elimination step on resin. Among the scavengers used, TIS provedt ob em ore efficient than water.F urthermore, we analyzed the incorporation of Fmoc-Ser-OMe to the Ellman resin using PTSA as ac atalysta nd THF as the solvent. Our results revealT hp to be av aluable protecting group for Ser and Thr if appliedtoSPPS using the Fmoc/tBu strategy. Given the solubility of its peptidee thers ande ase of introduction,T hp might be particularly useful for the effective synthesis of Ser-or Thrrich peptides andf or the protection of unnatural w-hydroxy amino acids (allo-Thr derivatives and other b-hydroxya mino acids) that are difficult to synthesize.
Experimental Section
All reagents and solvents were obtained from commercial suppliers and were used without further purification, unless otherwise stated. 2-CTC resin and Fmoc-protected amino acids were purchased from GL Biochem Pvt. Ltd. (Shanghai, China). Ellman resin was supplied by Merck. NMR spectra ( 1 Ha nd 13 C) were recorded on aB ruker AvanceIII 400 MHz spectrometer.C hemical shift values are expressed in parts per million (ppm).For shorter reaction times (2-5 min), the reactions were manually stirred with aT eflon rod, whereas for longer reactions times (> 30 min), they were stirred on aU nimax 1010 shaker (Heidolph Instruments). Solvents were removed from the reacion under reduced pressure. All the reactions were performed at room temperature ( % 25 8C). Each reaction step was followed by washing of the peptide resin with DMF (4 1min) and CH 2 Cl 2 (4 1min). Analytical HPLC was performed on an Agilent 1100 system using aP henomenex C 18 column (3 mm, 4.6 50 mm;s olvent A: 0.1 %T FA in H 2 O; solvent B: 0.1 %T FA in CH 3 CN). LC-MS was performed on aS himadzu 2020 UFLC-MS instrument using an YMC-Triart C 18 column (5 mm, 4.6 150 mm;s olvent A: 0.1 %f ormic acid in H 2 O; solvent B: 0.1 %f ormic acid in CH 3 CN). Data processing was carried out using LabSolution software. High-resolution mass spectrometry (HRMS) was performed using aB ruker ESI-QTOF mass spectrometer in positive-ion mode.
Synthesis of Fmoc-Ser(Thp)-OH
PTSA (14.5 mg, 0.077 mmol) was added to as uspension of FmocSer-OH (500 mg, 1.52 mmol) and DHP (277 mL, 3.06 mmol) in CH 2 Cl 2 .T he mixture was allowed to react for 30 min at RT.A fterwards, the organic layer was washed with brine (3 20 mL) and water (3 20 mL) and then dried over Na 2 SO 4 and filtered. The solvent was evaporated under reduced pressure. The crude product was purified on as ilica column using n-hexane/EtOAc (1:1). The collected fractions were concentrated to afford aw hite solid (478 mg, 76 %y ield). 
PeptideS ynthesis with Ellman (DHP) resin
Fmoc-Ser-OMe (50 mg, 0.059 mmol) in CH 2 Cl 2 was added to Ellman (DHP) resin (50 mg, f = 1.18 mmol g À1 )a fter the latter was swelled in CH 2 Cl 2 for 10 min. PTSA (0.28 mg, 0.0015 mmol) in THF (1 mL) was added to the resin. The reaction was stirred for 30 min and the resin was then washed with CH 2 Cl 2 (2 5mL) and dried. The dried resin was used to study the lability of Fmoc-Ser-OMe from Ellman resin.
Lability Experiments
The protected Fmoc-Ser(Thp)-OH and Fmoc-Thr(Thp)-OH (1 mg) were treated at RT with cleavage cocktails (200 mL), which were CH 2 ). Initially,t he resin was activated overnight using thionyl chloride (10 %i nC H 2 Cl 2 )a nd then washed with CH 2 Cl 2 (2 5mL). Attachment of the first amino acid was performed by treating the resin with Fmoc-Leu-OH (3 equiv.) and N,Ndiisopropylethylamine (10 equiv) in CH 2 Cl 2 ,a nd allowing it to react for 60 min at 25 8C. Thereafter,t he resin was capped by adding MeOH (10 equiv.) to the mixture, which was stirred for 30 min at 25 8C. The resin was then washed with CH 2 Cl 2 (4 5mL) and DMF (5 5mL), and the Fmoc protecting group was removed by treating the resin with 20 %p iperidine in DMF (2 10 mL, each 10 min), followed by washing with DMF (2 5mL) and CH 2 Cl 2 (2 5mL).
The H-Leu-O-2CTC resin was divided into two portions and swelled in CH 2 Cl 2 (3 5mL) and then DMF (3 5mL). Fmoc-Ser(Thp)-OH (3 equiv.) was added to one portion and Fmoc-Thr(Thp)-OH (3 equiv.) was added to the other.A mino acids were coupled using N,N'-diisopropylcarbodiimide (3 equiv.) and Oxyma Pure (3 equiv.) in DMF with a3min pre-activation time for 1.5 ha t2 5 8C. The resins were washed with CH 2 Cl 2 (4 5mL) and DMF (2 5mL). The Fmoc protecting group was removed by treating the resins with 20 %p iperidine in DMF (2 10 mL, each 10 min), and then FmocAla-OH was incorporated as described above.
Cleavage Studies
For each cleavage study,s amples of Fmoc-Ala-Xxx(Thp)-Leu-O-2CTC resin (Xxx = Ser or Thr;5mg) were treated with mixtures of TFA/H 2 O/TIS/CH 2 Cl 2 (500 mL) at different percentages (Table 2) 
